Showing results (31-40 of 78) with videos related to
Sort By:
Pageof 8
Critical Care (London, England)|October 11, 2016
Impact of HIV infection on the presentation, outcome and host response in patients admitted to the intensive care unit with sepsis; a case control studyMaryse A Wiewel, Michaëla A Huson, Lonneke A van Vught, et al.Elife|December 11, 2020
The leukocyte non-coding RNA landscape in critically ill patients with sepsisBrendon P Scicluna, Fabrice Uhel, Lonneke A van Vught, et al.Critical Care (London, England)|August 7, 2016
Association of diabetes and diabetes treatment with the host response in critically ill sepsis patientsLonneke A van Vught, Brendon P Scicluna, Arie J Hoogendijk, et al.International Journal of Cardiology. Heart & Vasculature|May 24, 2024
Biomarker patterns in patients with cardiogenic shock versus septic shockElma J Peters, Martin S Frydland, Christian Hassager, et al.Critical Care (London, England)|December 13, 2022
Association between age and the host response in critically ill patients with sepsisErik H A Michels, Joe M Butler, Tom D Y Reijnders, et al.Critical Care Medicine|March 10, 2016
Admission Hyperglycemia in Critically Ill Sepsis Patients: Association With Outcome and Host ResponseLonneke A van Vught, Maryse A Wiewel, Peter M C Klein Klouwenberg, et al.The European Journal of General Practice|November 10, 2025
Implementing a sepsis prediction score in out-of-hours primary care: Feasibility and acceptability studyFeike J Loots, Lonneke A van Vught, Minou van den Brande, et al.Open Forum Infectious Diseases|December 15, 2022
Real-world Evidence of the Effects of Novel Treatments for COVID-19 on Mortality: A Nationwide Comparative Cohort Study of Hospitalized Patients in the First, Second, Third, and Fourth Waves in the NetherlandsMarleen A Slim, Brent Appelman, Hessel Peters-Sengers, et al.The European Respiratory Journal|August 27, 2021
Blood leukocyte transcriptomes in Gram-positive and Gram-negative community-acquired pneumoniaLiza Pereverzeva, Fabrice Uhel, Hessel Peters Sengers, et al.Respiratory Research|December 24, 2022
Anti-C5a antibody vilobelimab treatment and the effect on biomarkers of inflammation and coagulation in patients with severe COVID-19: a substudy of the phase 2 PANAMO trialEndry H T Lim, Alexander P J Vlaar, Lieuwe D J Bos, et al.Pageof 8